Skip to content
WELCOME10 — 10% OFF YOUR FIRST ORDER  ·  FREE SHIPPING OVER $300 CAD  ·  COA ON EVERY ORDER

What to Check When Your Tirzepatide Arrives

Not every irregularity on arrival is a defect, and not every compound is defective under the same conditions. Here is what actually matters when a Tirzepatide shipment arrives.

Lipidated dual receptor agonist (GIP / GLP-1), 39-residue chainMetabolic

In plain English

Dry tirzepatide handles warm transit well. The meaningful check on arrival is the powder cake: intact and dry is good, collapsed or liquefied means moisture got in and the vial should be rejected.

What Tirzepatide actually is

Tirzepatide is an engineered molecule acting on two receptors in the gut-hormone system involved in blood-sugar regulation. It carries a design detail that is very widely misreported: it was built on a GIP backbone and then modified to also engage GLP-1, whereas most compounds in its class went the other way round.

Supplied for laboratory research use only — not for human or animal use.

Research-grade Tirzepatide

Third-party tested by HPLC and LC-MS, ≥99% purity, with a Certificate of Analysis on every order. Ships across Canada.

Technical detail below

Arrival inspection for Tirzepatide

Dry tirzepatide tolerates ambient transit well. The meaningful arrival check is the cake: intact and dry is good, collapsed or liquefied indicates moisture exposure and should be rejected.

Storage on arrival

On receiptSealed at -20 °C. Robust as dry powder.
Once reconstitutedRefrigerate at 2–8 °C. The albumin-binding modification confers good solution stability.
Working windowCommonly worked with for 4–6 weeks at 2–8 °C.

Documentation to check

Confirm the mass near 4813.5 Da. As with retatrutide, aggregate content is the check that RP-HPLC purity alone will not give you. For a 39-residue synthesis, also review the chromatogram for closely eluting deletion sequences.

What Tirzepatide is studied for

Dual incretin engagement

Simultaneous GIP and GLP-1 receptor activity from a GIP-derived backbone.

Insulin secretion and glucagon suppression

Core metabolic research endpoints for the incretin class.

Gastric emptying

A well-characterised GLP-1 pathway effect studied in metabolic models.

GIP receptor pharmacology

Whether GIP agonism or antagonism is the productive direction remains an active research debate.

Summarizes published preclinical literature. Provided for research reference only; not a claim of efficacy or a description of human use.

More Tirzepatide reference

Shipping & Receiving reference for other compounds

Tirzepatide overview Tirzepatide calculatorTirzepatide product details

Tirzepatide is supplied strictly as a research chemical for in-vitro laboratory and research use only. It is not intended for human or animal consumption, diagnostic, or therapeutic use. This page is educational laboratory-handling reference information — not medical advice, not usage guidance, and not a protocol.